Oarsman Capital, Inc. Novartis Ag Transaction History

Oarsman Capital, Inc.

$450 Million
Q2 2024

A detailed history of Oarsman Capital, Inc. transactions in Novartis Ag stock. As of the latest transaction made, Oarsman Capital, Inc. holds 5,860 shares of NVS stock, worth $677,474. This represents 0.14% of its overall portfolio holdings.

Number of Shares

5,860

Previous 6,187 5.29%

Holding current value

$677,474

Previous $598,000 4.18%

% of portfolio

0.14%

Previous 0.14%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$92.57 - $107.37 $30,270 - $35,109	-327 Reduced 5.29%	5,860 $623,000
Q1 2024 May 15, 2024	SELL	$95.27 - $108.47 $12,194 - $13,884	-128 Reduced 2.03%	6,187 $598,000
Q4 2023 Feb 16, 2024	BUY	$92.27 - $101.54 $9,042 - $9,950	98 Added 1.58%	6,315 $637,000
Q3 2023 Oct 27, 2023	SELL	$94.73 - $105.13 $6,157 - $6,833	-65 Reduced 1.03%	6,217 $633,000
Q2 2023 Aug 10, 2023	SELL	$92.52 - $104.91 $18,041 - $20,457	-195 Reduced 3.01%	6,282 $633,000
Q1 2023 May 11, 2023	SELL	$80.03 - $92.81 $25,209 - $29,235	-315 Reduced 4.64%	6,477 $595,000
Q4 2022 Feb 09, 2023	SELL	$75.55 - $92.52 $27,575 - $33,769	-365 Reduced 5.1%	6,792 $616,000
Q3 2022 Nov 10, 2022	BUY	$74.61 - $87.26 $533,983 - $624,519	7,157 New	7,157 $544,000
Q2 2022 Aug 10, 2022	SELL	$80.52 - $93.75 $55,558 - $64,687	-690 Reduced 8.54%	7,392 $625,000
Q1 2022 May 11, 2022	BUY	$80.11 - $90.62 $44,060 - $49,841	550 Added 7.3%	8,082 $709,000
Q4 2021 Feb 10, 2022	SELL	$79.7 - $88.13 $63,361 - $70,063	-795 Reduced 9.55%	7,532 $659,000
Q3 2021 Nov 12, 2021	SELL	$81.78 - $95.14 $33,120 - $38,531	-405 Reduced 4.64%	8,327 $681,000
Q2 2021 Aug 12, 2021	SELL	$85.24 - $94.15 $879,591 - $971,533	-10,319 Reduced 54.17%	8,732 $797,000
Q1 2021 May 12, 2021	SELL	$83.5 - $98.47 $418,919 - $494,023	-5,017 Reduced 20.85%	19,051 $1.63 Million
Q4 2020 Feb 11, 2021	SELL	$78.07 - $94.43 $20,766 - $25,118	-266 Reduced 1.09%	24,068 $2.27 Million
Q3 2020 Nov 12, 2020	SELL	$82.14 - $91.0 $198,368 - $219,765	-2,415 Reduced 9.03%	24,334 $2.12 Million
Q2 2020 Aug 13, 2020	BUY	$80.93 - $91.1 $1.23 Million - $1.39 Million	15,234 Added 132.3%	26,749 $2.34 Million
Q1 2020 May 13, 2020	SELL	$70.67 - $99.01 $750,656 - $1.05 Million	-10,622 Reduced 47.98%	11,515 $949,000
Q4 2019 Feb 13, 2020	BUY	$84.35 - $95.37 $796,854 - $900,960	9,447 Added 74.44%	22,137 $2.1 Million
Q3 2019 Nov 12, 2019	SELL	$85.54 - $94.26 $12,831 - $14,139	-150 Reduced 1.17%	12,690 $1.1 Million
Q2 2019 Aug 13, 2019	SELL	$75.4 - $92.8 $1,357 - $1,670	-18 Reduced 0.14%	12,840 $1.17 Million
Q1 2019 May 14, 2019	SELL	$75.32 - $86.15 $22,595 - $25,845	-300 Reduced 2.28%	12,858 $1.24 Million
Q4 2018 Feb 13, 2019	SELL	$73.66 - $82.02 $10,312 - $11,482	-140 Reduced 1.05%	13,158 $1.13 Million
Q3 2018 Nov 07, 2018	SELL	$66.94 - $77.43 $16,735 - $19,357	-250 Reduced 1.85%	13,298 $1.15 Million
Q2 2018 Aug 10, 2018	BUY	$64.91 - $73.36 $106,712 - $120,603	1,644 Added 13.81%	13,548 $1.02 Million
Q1 2018 May 14, 2018	BUY	$70.39 - $84.15 $7,672 - $9,172	109 Added 0.92%	11,904 $962,000
Q4 2017 Feb 08, 2018	SELL	$72.33 - $77.64 $11,934 - $12,810	-165 Reduced 1.38%	11,795 $990,000
Q3 2017 Nov 13, 2017	BUY	$74.14 - $77.27 $886,714 - $924,149	11,960	11,960 $1.03 Million

Others Institutions Holding NVS

# of Institutions

1,426

Shares Held

138M

Call Options Held

1.48M

Put Options Held

1.54M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $249B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oarsman Capital, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Oarsman Capital, Inc. with notifications on news.

Account

Oarsman Capital, Inc. Novartis Ag Transaction History